bluebird bio, Inc. NASDAQ:BLUE

bluebird bio stock price today

$4.99
-3.78
-43.17%
Financial Health
0
1
2
3
4
5
6
7
8
9

bluebird bio stock price monthly change

+619.67%
month

bluebird bio stock price quarterly change

+619.67%
quarter

bluebird bio stock price yearly change

+527.14%
year

bluebird bio key metrics

Market Cap
76.22M
Enterprise value
168.61M
P/E
-0.94
EV/Sales
47.65
EV/EBITDA
-0.57
Price/Sales
0.06
Price/Book
N/A
PEG ratio
-0.01
EPS
-0.62
Revenue
21.72M
EBITDA
-228.11M
Income
-78.36M
Revenue Q/Q
17353.52%
Revenue Y/Y
322.58%
Profit margin
-8449.85%
Oper. margin
-8837.84%
Gross margin
-184.44%
EBIT margin
-8837.84%
EBITDA margin
-1050.01%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

bluebird bio stock price history

bluebird bio stock forecast

bluebird bio financial statements

bluebird bio, Inc. (NASDAQ:BLUE): Profit margin
Dec 2022 62K 32.23M 51987.1%
Mar 2023 2.38M 34.04M 1429.78%
Jun 2023 6.89M -72.90M -1058.17%
Sep 2023 12.39M -71.73M -578.85%
bluebird bio, Inc. (NASDAQ:BLUE): Analyst Estimates
Sep 2025 84.91M -16.63M -19.59%
Dec 2025 99.26M -9.81M -9.89%
Mar 2026 93.42M -23.48M -25.14%
Jun 2026 108.90M -18.08M -16.6%
  • Analysts Price target

  • Financials & Ratios estimates

bluebird bio, Inc. (NASDAQ:BLUE): Debt to assets
Dec 2022 554902000 358.55M 64.62%
Mar 2023 692736000 337.99M 48.79%
Jun 2023 663393000 374.37M 56.43%
Sep 2023 613608000 391.07M 63.73%
bluebird bio, Inc. (NASDAQ:BLUE): Cash Flow
Dec 2022 -56.27M 103.24M -115K
Mar 2023 -86.63M 82.13M 130.45M
Jun 2023 -72.72M 6.94M -445K
Sep 2023 -61.84M 62.08M -42K

bluebird bio alternative data

bluebird bio, Inc. (NASDAQ:BLUE): Employee count
Aug 2023 323
Sep 2023 323
Oct 2023 323
Nov 2023 323
Dec 2023 323
Jan 2024 323
Feb 2024 323
Mar 2024 323
Apr 2024 323
May 2024 323
Jun 2024 323
Jul 2024 323

bluebird bio other data

58.17% +3.34%
of BLUE is owned by hedge funds
61.62M +3.53M
shares is hold by hedge funds

bluebird bio, Inc. (NASDAQ:BLUE): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 3759
Feb 2024 0 9810
Mar 2024 0 17438
Jun 2024 0 3834
Sep 2024 0 35786
Dec 2024 0 3795
Transaction Date Insider Security Shares Price per share Total value Source
Sale
OBENSHAIN ANDREW director, officer: President an..
Common Stock 971 $0.42 $405
Sale
COLVIN RICHARD A officer: Chief Medical Officer
Common Stock 2,824 $0.42 $1,178
Sale
KLIMA THOMAS J officer: See Remarks
Common Stock 1,006 $0.53 $529
Sale
OBENSHAIN ANDREW director, officer: President an..
Common Stock 34,780 $0.53 $18,260
Sale
KLIMA THOMAS J officer: See Remarks
Common Stock 3,834 $0.97 $3,727
Sale
OBENSHAIN ANDREW director, officer: President an..
Common Stock 6,095 $1.53 $9,313
Sale
KLIMA THOMAS J officer: See Remarks
Common Stock 4,573 $1.53 $6,988
Sale
COLVIN RICHARD A officer: Chief Medical Officer
Common Stock 6,770 $1.53 $10,345
Sale
KLIMA THOMAS J officer: See Remarks
Common Stock 2,714 $0.9 $2,451
Sale
VITTIGLIO JOSEPH officer: Chief Business & Legal..
Common Stock 5,217 $0.9 $4,711
Patent
Application
Filling date: 28 Jan 2022 Issue date: 18 Aug 2022
Application
Filling date: 27 Mar 2020 Issue date: 26 May 2022
Application
Filling date: 20 Mar 2020 Issue date: 19 May 2022
Application
Filling date: 22 Jan 2020 Issue date: 7 Apr 2022
Application
Filling date: 13 Dec 2019 Issue date: 27 Jan 2022
Application
Filling date: 14 Jun 2019 Issue date: 26 Aug 2021
Application
Filling date: 14 Dec 2018 Issue date: 5 Aug 2021
Sunday, 8 December 2024
businesswire.com
Saturday, 7 December 2024
businesswire.com
Friday, 6 December 2024
businesswire.com
Wednesday, 4 December 2024
businesswire.com
businesswire.com
Monday, 2 December 2024
prnewswire.com
Wednesday, 27 November 2024
reuters.com
Monday, 25 November 2024
prnewswire.com
Wednesday, 20 November 2024
businesswire.com
seekingalpha.com
Friday, 15 November 2024
benzinga.com
proactiveinvestors.com
Thursday, 14 November 2024
seekingalpha.com
zacks.com
Friday, 8 November 2024
zacks.com
Tuesday, 5 November 2024
businesswire.com
Tuesday, 8 October 2024
gurufocus.com
Friday, 4 October 2024
businesswire.com
Wednesday, 2 October 2024
gurufocus.com
Friday, 27 September 2024
businesswire.com
Tuesday, 24 September 2024
reuters.com
businesswire.com
Monday, 16 September 2024
247wallst.com
Friday, 12 July 2024
globenewswire.com
Wednesday, 3 July 2024
newsfilecorp.com
Thursday, 27 June 2024
globenewswire.com
Tuesday, 25 June 2024
newsfilecorp.com
Monday, 17 June 2024
investorplace.com
Tuesday, 4 June 2024
globenewswire.com
newsfilecorp.com
  • What's the price of bluebird bio stock today?

    One share of bluebird bio stock can currently be purchased for approximately $4.99.

  • When is bluebird bio's next earnings date?

    Unfortunately, bluebird bio's (BLUE) next earnings date is currently unknown.

  • Does bluebird bio pay dividends?

    No, bluebird bio does not pay dividends.

  • How much money does bluebird bio make?

    bluebird bio has a market capitalization of 76.22M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 720.04% to 29.5M US dollars.

  • What is bluebird bio's stock symbol?

    bluebird bio, Inc. is traded on the NASDAQ under the ticker symbol "BLUE".

  • What is bluebird bio's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of bluebird bio?

    Shares of bluebird bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are bluebird bio's key executives?

    bluebird bio's management team includes the following people:

    • Mr. Nick Leschly Pres & Director(age: 52, pay: $841,950)
    • Mr. William D. Baird III Principal Financial & Accounting Officer(age: 53, pay: $718,610)
  • How many employees does bluebird bio have?

    As Jul 2024, bluebird bio employs 323 workers.

  • When bluebird bio went public?

    bluebird bio, Inc. is publicly traded company for more then 12 years since IPO on 19 Jun 2013.

  • What is bluebird bio's official website?

    The official website for bluebird bio is bluebirdbio.com.

  • Where are bluebird bio's headquarters?

    bluebird bio is headquartered at 60 Binney Street, Cambridge, MA.

  • How can i contact bluebird bio?

    bluebird bio's mailing address is 60 Binney Street, Cambridge, MA and company can be reached via phone at +33 94999300.

bluebird bio company profile:

bluebird bio, Inc.

bluebirdbio.com
Exchange:

NASDAQ

Full time employees:

375

Industry:

Biotechnology

Sector:

Healthcare

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.

60 Binney Street
Cambridge, MA 02142

CIK: 0001293971
ISIN: US09609G1004
CUSIP: 09609G100